Skip to content
Opening soonHORIZON-MISS-2027-02-CANCER-05HaDEAOne-off

Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

Pre-commercial procurement of affordable cancer innovations.

Horizon Europe pre-commercial procurement (PCP, €26 million) under the EU Mission on Cancer for affordable solutions for healthcare systems in the areas of cancer technologies, medical devices or medicines.

Opening soon
84
days until opening
Opens on 10 February 2027
HORIZON-MISS-2027-02-CANCER-05
View all deadlines
Beta

This grant database is in beta

Until the official launch on 1 January 2027 we are making the final improvements. Our editors check every scheme, but details may still be incomplete or out of date. Check the official publication before you apply.

In brief

What is Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines?

Who
A consortium of at least three independent organisations, of which at least two are public procurers from different EU Member States or Associated Countries and at least one is from a Member State. The procurement is prepared and carried out by public procurers, possibly together with private or NGO procurers, or by organisations mandated by those procurers; each procurer contributes financially.
General Annex B (Entities eligible for funding; Consortium composition); General Annex H (Requirements for all types of actions supporting PCP or PPI)
What for
A pre-commercial procurement (PCP) in which a group of procurers jointly procures the development of affordable, innovative solutions for healthcare systems in the areas of cancer technology, cancer medical devices or cancer medicines, so that these become available faster.
Topic HORIZON-MISS-2027-02-CANCER-05 (Expected Outcome; Scope)
What you get
A grant covering 100% of eligible costs, with PCP procurement costs also eligible; the Commission considers an EU contribution of €8-10 million per project appropriate. The indicative budget for the topic is €26 million, with 3 projects expected to be funded.
Topic HORIZON-MISS-2027-02-CANCER-05 (Expected EU contribution per project; Indicative budget; Legal and financial set-up); General Annex G, Funding rates
What you need to do
Submit a proposal in a single stage via the Funding & Tenders Portal between 10 February 2027 and 16 September 2027 (17:00 Brussels time) at the latest, using application form Part A and Part B. Independent experts evaluate and rank the proposals; results are expected around 5 months after the deadline.
Call HORIZON-MISS-2027-02 overview (Opening; Deadline); General Annexes E and F

Built from the details on this page, with nothing added by us.

Purpose & impact

Why does this scheme exist?

Making affordable cancer innovations available to healthcare systems faster.

01
Joint innovative procurement
Public procurers, possibly together with private ones, stimulate the competitive development of market-ready, affordable and innovative solutions in cancer care.
02
Patient-centred solutions
The selected solutions take into account the needs of people living with or after cancer, through research in which end users actively participate.
03
Opportunities for European suppliers
Procurers offer European health, technology and medtech companies, including start-ups and SMEs, opportunities to bring affordable, safe and cost-efficient innovations with proven better health outcomes to the market.
04
First customer references
Procurers support commercialisation by giving their suppliers first customer references for validation and an initial pilot deployment.
05
Sharing good practices
Policymakers, healthcare providers, professionals, patients and carers exchange good practices and adopt the best treatment, technology and device solutions.
Description

About the scheme

Compiled from passages of the scheme's official publication, with nothing added by us.

Pre-commercial procurement (PCP) actions target consortia of procurers with similar needs that want to procure together the development of affordable, innovative solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines.

Am I eligible?

Conditions

Quoted verbatim from the scheme, with the article that sets each condition.

01
To be eligible for funding, applicants must be established in one of the following countries: – the Member States of the European Union, including their outermost regions: … – countries associated to Horizon Europe
02
Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.
03
Applications for ‘Pre-commercial procurement’ actions and ‘Public procurement of innovative solutions’ actions must also fulfil the eligibility criteria of three independent legal entities as beneficiaries as explained above, out of which a minimum of two beneficiaries must be independent legal entities that are public procurers … each established in a different Member State or Associated Country and with at least one of them established in a Member State.
04
Applications will only be considered eligible if their content corresponds, wholly or in part, to the topic description for which it is submitted.
05
The specific conditions for actions with PCP/PPI procurements in section H of the General Annexes apply to grants funded under this topic.
06
The PCP/PPI must be prepared and executed by one of the following: - by one or more public procurer(s), plus possibly one or more private and/or NGO procurer(s) that provide similar services of public interest, that is (are) responsible for the acquisition and/or regulatory strategy of the relevant innovative solutions and aim to obtain ambitious quality and efficiency improvements in the area of the PCP/PPI; or - by entities with a mandate from one or more of these procurers to act on their behalf in the procurement (e.g. central purchasing bodies).
07
Each procurer in the buyers’ group must contribute financially to the total budget necessary to jointly finance the PCP
08
Projects that aim to implement a PCP/PPI must contain a preparation and execution stage.
Company size
All sizes
Micro< 10 FTE
Small< 50 FTE
Medium< 250 FTE
Large≥ 250 FTE
Themes
Onderzoek, ontwikkeling en innovatieGezondheid, zorg en welzijn
Project phase
DevelopmentDemonstration
Funding

What do you get?

100% of your eligible project costs.

Note on the maximum
No binding maximum; the Commission considers an EU contribution of €8-10 million per project appropriate (other amounts not excluded). PCP procurement costs are eligible (General Annex H).
€26m · Indicative topic budget, 3 projects expected to be funded.
Budget status
Not published by the source
The sources do not say how much budget is left (checked 18 November 2026).
No double funding: an action may receive only one grant from the EU budget (except EU Synergy grants) and the same costs may never be declared under two different EU actions (General Annex G).
Type
Direct grant (non-repayable)
Calendar

Deadlines & cycles

10
FEB
HORIZON-MISS-2027-02-CANCER-05 opens 10 February 2027
Call HORIZON-MISS-2027-02, overview of this call
Cycle: Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F). General Annex F, Indicative timetable for evaluation and for signature of the grant agreement
Application

How do you apply?

Pre-registration
Required, before the full application
Required attachments
  • Application form Part A: administrative data of the participants and summarised budget (to be completed online)
  • Application form Part B: technical description of the project (PDF, maximum 40 pages)
Procedure
Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Health and Digital Executive Agency (HaDEA).
Eligible costs

What can the money be spent on?

Personnel costs
Materials
Not eligible
Subcontracting
Equipment
Land
Not eligible
Buildings
Not eligible
Overheads
Travel costs
Other costs
Downloads

Files & forms

Changes

What has changed?

10 November 2026scheme · version 5

Subtitle
Subtitle: ChangedShow
Before

Precommerciële inkoop van betaalbare kankerinnovaties.

Now

Pre-commercial procurement of affordable cancer innovations.

Description
Description: ChangedShow
Before

Groepen publieke inkopers uit de zorg kopen gezamenlijk onderzoek en ontwikkeling in van betaalbare oplossingen voor kankertechnologieën, medische hulpmiddelen of geneesmiddelen. De specifieke voorwaarden voor PCP uit General Annex H zijn van toepassing; PCP-inkoopkosten zijn subsidiabel.

Now

Groups of public procurers from the healthcare sector jointly procure research and development of affordable solutions for cancer technologies, medical devices or medicines. The specific conditions for PCP in General Annex H apply; PCP procurement costs are eligible.

Short description
Short description: ChangedShow
Before

Horizon Europe precommerciële inkoop (PCP, € 26 mln) binnen de EU-missie Kanker voor betaalbare oplossingen voor zorgstelsels op het gebied van kankertechnologieën, medische hulpmiddelen of geneesmiddelen.

Now

Horizon Europe pre-commercial procurement (PCP, €26 million) under the EU Mission on Cancer for affordable solutions for healthcare systems in the areas of cancer technologies, medical devices or medicines.

Cycle
Cycle: ChangedShow
Before

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Now

Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F).

Note on the total budget
Note on the total budget: ChangedShow
Before

Indicatief topicbudget, naar verwachting 3 projecten.

Now

Indicative topic budget, 3 projects expected to be funded.

Note on the maximum
Note on the maximum: ChangedShow
Before

Geen bindend maximum; de Commissie acht € 8 tot 10 mln EU-bijdrage per project passend (andere bedragen niet uitgesloten). PCP-inkoopkosten zijn subsidiabel (General Annex H).

Now

No binding maximum; the Commission considers an EU contribution of €8-10 million per project appropriate (other amounts not excluded). PCP procurement costs are eligible (General Annex H).

Cumulation
Cumulation: ChangedShow
Before

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Now

No double funding: an action may receive only one grant from the EU budget (except EU Synergy grants) and the same costs may never be declared under two different EU actions (General Annex G).

Search engine title
Precommerciële inkoop kankerinnovaties (EU-missie) becomes Cancer innovation pre-commercial procurement (EU Mission)
Search engine description
Search engine description: ChangedShow
Before

Horizon Europe PCP van € 26 mln waarmee zorginkopers betaalbare oplossingen voor kankertechnologie, hulpmiddelen of geneesmiddelen laten ontwikkelen.

Now

Horizon Europe PCP of €26 million through which healthcare procurers have affordable solutions for cancer technology, devices or medicines developed.

Keywords
EU-missie Cancer, Horizon Europe, HORIZON-MISS-2027-02-CANCER-05, kankertechnologie, medische hulpmiddelen, precommerciële inkoop, zorginkoop becomes cancer technology, EU Mission Cancer, healthcare procurement, Horizon Europe, HORIZON-MISS-2027-02-CANCER-05, medical devices, pre-commercial procurement
Language
Dutch (Netherlands) becomes British English
Required attachments
Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 40 pagina's) becomes Application form Part A: administrative data of the participants and summarised budget (to be completed online); Application form Part B: technical description of the project (PDF, maximum 40 pages)
Procedure
Procedure: ChangedShow
Before

Aanvragen via het Funding & Tenders Portal met een EU Login en een PIC-nummer; single-stage; deadline 17:00 uur Brusselse tijd; beheerd door European Health and Digital Executive Agency (HaDEA).

Now

Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Health and Digital Executive Agency (HaDEA).

Why this scheme
Why this scheme: ChangedShow
Before

Betaalbare kankerinnovaties sneller beschikbaar voor zorgstelsels.

Now

Making affordable cancer innovations available to healthcare systems faster.

In brief
In brief: ChangedShow
Before

Who: Een consortium van ten minste drie onafhankelijke organisaties, waarvan minstens twee publieke inkopers uit verschillende EU-lidstaten of geassocieerde landen en minstens één uit een lidstaat. De inkoop wordt voorbereid en uitgevoerd door publieke inkopers, eventueel samen met private of ngo-inkopers, of door organisaties met een mandaat van die inkopers; elke inkoper draagt financieel bij.

What for: Een precommerciële inkoop (PCP) waarin een groep inkopers samen de ontwikkeling van betaalbare, innovatieve oplossingen voor zorgstelsels inkoopt op het gebied van kankertechnologie, medische hulpmiddelen voor kanker of kankergeneesmiddelen, zodat die sneller beschikbaar komen.

What you get: Een subsidie van 100% van de subsidiabele kosten, waarbij ook de PCP-inkoopkosten subsidiabel zijn; de Commissie acht een EU-bijdrage van € 8 tot € 10 miljoen per project passend. Het indicatieve budget voor het topic is € 26 miljoen, naar verwachting voor 3 projecten.

What you need to do: Dien van 10 februari 2027 tot uiterlijk 16 september 2027 (17:00 uur Brusselse tijd) in één ronde een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A en B. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt naar verwachting circa 5 maanden na de deadline.

Now

Who: A consortium of at least three independent organisations, of which at least two are public procurers from different EU Member States or Associated Countries and at least one is from a Member State. The procurement is prepared and carried out by public procurers, possibly together with private or NGO procurers, or by organisations mandated by those procurers; each procurer contributes financially.

What for: A pre-commercial procurement (PCP) in which a group of procurers jointly procures the development of affordable, innovative solutions for healthcare systems in the areas of cancer technology, cancer medical devices or cancer medicines, so that these become available faster.

What you get: A grant covering 100% of eligible costs, with PCP procurement costs also eligible; the Commission considers an EU contribution of €8-10 million per project appropriate. The indicative budget for the topic is €26 million, with 3 projects expected to be funded.

What you need to do: Submit a proposal in a single stage via the Funding & Tenders Portal between 10 February 2027 and 16 September 2027 (17:00 Brussels time) at the latest, using application form Part A and Part B. Independent experts evaluate and rank the proposals; results are expected around 5 months after the deadline.

Goals
Goals: 5 removed, 5 newShow
Removed

Gezamenlijke innovatieve inkoop Publieke inkopers, eventueel samen met private, stimuleren in de kankerzorg de concurrerende ontwikkeling van marktrijpe, betaalbare en innovatieve oplossingen.

Oplossingen vanuit de patiënt De gekozen oplossingen houden rekening met de behoeften van mensen die met of na kanker leven, via onderzoek waarin eindgebruikers actief meedoen.

Kansen voor Europese leveranciers Inkopers bieden Europese gezondheids-, technologie- en medtechbedrijven, waaronder start-ups en mkb, kansen om betaalbare, veilige en kostenefficiënte innovaties met bewezen betere gezondheidsuitkomsten op de markt te brengen.

Eerste klantreferenties Inkopers helpen de commercialisering door hun leveranciers eerste klantreferenties te geven voor validatie en een eerste proefinzet.

Goede praktijken delen Beleidsmakers, zorgaanbieders, professionals, patiënten en mantelzorgers wisselen goede praktijken uit en nemen de beste behandel-, technologie- en hulpmiddeloplossingen over.

New

Joint innovative procurement Public procurers, possibly together with private ones, stimulate the competitive development of market-ready, affordable and innovative solutions in cancer care.

Patient-centred solutions The selected solutions take into account the needs of people living with or after cancer, through research in which end users actively participate.

Opportunities for European suppliers Procurers offer European health, technology and medtech companies, including start-ups and SMEs, opportunities to bring affordable, safe and cost-efficient innovations with proven better health outcomes to the market.

First customer references Procurers support commercialisation by giving their suppliers first customer references for validation and an initial pilot deployment.

Sharing good practices Policymakers, healthcare providers, professionals, patients and carers exchange good practices and adopt the best treatment, technology and device solutions.

Show 4 earlier versions

20 October 2026scheme · version 4

Conditions
Conditions: 2 removed, 8 newShow
Removed

Consortium van minstens drie partners Minstens drie onafhankelijke juridische entiteiten uit drie verschillende EU-lidstaten of geassocieerde landen, waarvan minstens één uit een lidstaat (General Annex B).

Voorwaarden voor precommerciële inkoop De specifieke voorwaarden voor PCP-acties uit General Annex H gelden, onder meer de samenstelling van de inkopersgroep van publieke inkopers uit verschillende lidstaten of geassocieerde landen.

New

To be eligible for funding, applicants must be established in one of the following countries: – the Member States of the European Union, including their outermost regions: … – countries associated to Horizon Europe

Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.

Applications for ‘Pre-commercial procurement’ actions and ‘Public procurement of innovative solutions’ actions must also fulfil the eligibility criteria of three independent legal entities as beneficiaries as explained above, out of which a minimum of two beneficiaries must be independent legal entities that are public procurers … each established in a different Member State or Associated Country and with at least one of them established in a Member State.

Applications will only be considered eligible if their content corresponds, wholly or in part, to the topic description for which it is submitted.

The specific conditions for actions with PCP/PPI procurements in section H of the General Annexes apply to grants funded under this topic.

The PCP/PPI must be prepared and executed by one of the following: - by one or more public procurer(s), plus possibly one or more private and/or NGO procurer(s) that provide similar services of public interest, that is (are) responsible for the acquisition and/or regulatory strategy of the relevant innovative solutions and aim to obtain ambitious quality and efficiency improvements in the area of the PCP/PPI; or - by entities with a mandate from one or more of these procurers to act on their behalf in the procurement (e.g. central purchasing bodies).

Each procurer in the buyers’ group must contribute financially to the total budget necessary to jointly finance the PCP

Projects that aim to implement a PCP/PPI must contain a preparation and execution stage.

In brief
In brief: AddedShow
Now

Who: Een consortium van ten minste drie onafhankelijke organisaties, waarvan minstens twee publieke inkopers uit verschillende EU-lidstaten of geassocieerde landen en minstens één uit een lidstaat. De inkoop wordt voorbereid en uitgevoerd door publieke inkopers, eventueel samen met private of ngo-inkopers, of door organisaties met een mandaat van die inkopers; elke inkoper draagt financieel bij.

What for: Een precommerciële inkoop (PCP) waarin een groep inkopers samen de ontwikkeling van betaalbare, innovatieve oplossingen voor zorgstelsels inkoopt op het gebied van kankertechnologie, medische hulpmiddelen voor kanker of kankergeneesmiddelen, zodat die sneller beschikbaar komen.

What you get: Een subsidie van 100% van de subsidiabele kosten, waarbij ook de PCP-inkoopkosten subsidiabel zijn; de Commissie acht een EU-bijdrage van € 8 tot € 10 miljoen per project passend. Het indicatieve budget voor het topic is € 26 miljoen, naar verwachting voor 3 projecten.

What you need to do: Dien van 10 februari 2027 tot uiterlijk 16 september 2027 (17:00 uur Brusselse tijd) in één ronde een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A en B. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt naar verwachting circa 5 maanden na de deadline.

18 October 2026scheme · version 3

About the scheme
About the scheme: AddedShow
Now

Pre-commercial procurement (PCP) actions target consortia of procurers with similar needs that want to procure together the development of affordable, innovative solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines.

16 October 2026scheme · version 2

Cycle
Cycle: AddedShow
Now

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Cumulation
Cumulation: AddedShow
Now

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Keywords
Added: EU-missie Cancer, Horizon Europe, HORIZON-MISS-2027-02-CANCER-05, kankertechnologie, medische hulpmiddelen, precommerciële inkoop, zorginkoop
Required attachments
Added: Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 40 pagina's)
Goals
Goals: 5 newShow
New

Gezamenlijke innovatieve inkoop Publieke inkopers, eventueel samen met private, stimuleren in de kankerzorg de concurrerende ontwikkeling van marktrijpe, betaalbare en innovatieve oplossingen.

Oplossingen vanuit de patiënt De gekozen oplossingen houden rekening met de behoeften van mensen die met of na kanker leven, via onderzoek waarin eindgebruikers actief meedoen.

Kansen voor Europese leveranciers Inkopers bieden Europese gezondheids-, technologie- en medtechbedrijven, waaronder start-ups en mkb, kansen om betaalbare, veilige en kostenefficiënte innovaties met bewezen betere gezondheidsuitkomsten op de markt te brengen.

Eerste klantreferenties Inkopers helpen de commercialisering door hun leveranciers eerste klantreferenties te geven voor validatie en een eerste proefinzet.

Goede praktijken delen Beleidsmakers, zorgaanbieders, professionals, patiënten en mantelzorgers wisselen goede praktijken uit en nemen de beste behandel-, technologie- en hulpmiddeloplossingen over.

7 October 2026scheme · version 1 · first publication

Source

Contact & source

Funding body
European Health and Digital Executive Agency
Last verified
17 November 2026 by the Twin editors
Start your application

Start your HORIZON-MISS-2027-02-CANCER-05 application
in Twin.

Twin helps you write your application, based on the scheme and your own project documents. You stay in control of every text.